18.10.2021 20:52:00
|
Lilly Declares Fourth-Quarter 2021 Dividend
INDIANAPOLIS, Oct. 18, 2021 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2021 of $0.85 per share on outstanding common stock.
The dividend is payable on December 10, 2021 to shareholders of record at the close of business on November 15, 2021.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news. F-LLY
Lilly Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) related to expected dividend payments and reflects Lilly's current beliefs and expectations. However, there are significant risks and uncertainties in pharmaceutical research and development, as well as in business development activities and capital allocation strategies related to the company's business and actual results may differ materially due to various factors. For a further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, please see Lilly's most recent Forms 10-K and 10-Q filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.
Refer to:
Jordan Bishop; bishop_jordan@lilly.com; 317-473-5712 (Media)
Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-declares-fourth-quarter-2021-dividend-301402561.html
SOURCE Eli Lilly and Company
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
06.02.25 |
Eli Lilly expects to beat profit forecasts on obesity drug demand (Financial Times) | |
06.02.25 |
Ausblick: Eli Lilly legt Quartalsergebnis vor (finanzen.net) | |
04.02.25 |
S&P 500-Titel Eli Lilly-Aktie: So viel Gewinn hätte eine Eli Lilly-Investition von vor einem Jahr eingebracht (finanzen.at) | |
28.01.25 |
S&P 500-Titel Eli Lilly-Aktie: So viel Gewinn hätte eine Investition in Eli Lilly von vor 10 Jahren abgeworfen (finanzen.at) | |
22.01.25 |
Erste Schätzungen: Eli Lilly stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
21.01.25 |
S&P 500-Papier Eli Lilly-Aktie: So viel Gewinn hätte ein Eli Lilly-Investment von vor 5 Jahren abgeworfen (finanzen.at) | |
17.01.25 |
Aufschläge in New York: S&P 500 klettert zum Handelsende (finanzen.at) | |
17.01.25 |
Börse New York in Grün: S&P 500 nachmittags stärker (finanzen.at) |
Analysen zu Eli Lillymehr Analysen
20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Eli Lilly | 853,00 | 0,24% |
|